Malcolm Hooper

Malcolm Hooper is a prominent British pharmacologist and Emeritus Professor of Medicinal Chemistry at the University of Sunderland. He is best known for his extensive research and advocacy in the field of Myalgic Encephalomyelitis (ME) and Chronic Fatigue Syndrome (CFS).

Early Life and Education

Malcolm Hooper was born in England. He received his BSc in Pharmacy from the University of London, followed by a PhD in Medicinal Chemistry from the same institution.

Career

Hooper began his career as a lecturer at the University of Sunderland, where he later became a professor. His research primarily focused on drug metabolism and the design of new drugs. He has published numerous scientific papers in these areas.

In the late 1990s, Hooper shifted his focus to ME and CFS, conditions that were poorly understood and often dismissed by the medical community. He has since become a leading advocate for patients suffering from these conditions, challenging the prevailing view that they are primarily psychological in nature.

Advocacy

Hooper has been a vocal critic of the PACE trial, a large-scale study of treatments for ME and CFS. He has argued that the trial was flawed in its design and interpretation of results, leading to misleading conclusions about the effectiveness of cognitive behavioral therapy and graded exercise therapy.

He has also been involved in the International Consensus Criteria for ME, which aims to provide a more accurate and comprehensive definition of the condition.

Recognition

Hooper's work has been recognized by several organizations. He was awarded the Order of the British Empire for his services to pharmacy and medicine.

See Also

• Myalgic Encephalomyelitis
• Chronic Fatigue Syndrome
• PACE trial
• International Consensus Criteria

External Links

• University of Sunderland